Clinical trial
A Phase III Randomized, Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome
NCT00296036 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Randomized, Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- Not reported
- Enrollment
- 137 (actual)
- Sites
- 231
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, drug/agent toxicity by tissue/organ, unspecified adult solid tumor, protocol specific